High-Throughput, Fluorescence-Based Esterase Activity Assay for Assessing Polysorbate Degradation Risk during

Adithi C Bhargava1, Kathryn Mains2,3, Albert Siu2

  • 1Pharmaceutical Development, Genentech Inc., 1 DNA Way, MS 562a, South San Francisco, CA, 94080, USA. chandrasekhara.adithi@gene.com.

Summary

A new esterase activity assay using surrogate substrates can predict polysorbate degradation in monoclonal antibody drug products. This method offers rapid characterization and risk assessment during drug development.

Related Concept Videos